Updates to Recurrent Uncomplicated Urinary Tract Infections in Women: AUA/CUA/SUFU Guideline

Purpose: In 2019 the American Urological Association (AUA) released the evidence-based guideline Recurrent Uncomplicated Urinary Tract Infections in Women: AUA/CUA/SUFU Guideline. Information supporting the guideline came from a 2019 systematic evidence review prepared for the AUA by the Pacific Northwest Evidence-based Practice Center (EPC). The AUA used evidence found for 11 Key Questions (Appendix C) in the EPC's report to derive 16 Guideline Statements. In 2021 the EPC conducted an Update Literature Review (ULR) assessing abstracts from new studies published since the 2019 systematic review. The AUA asked the EPC to further assess a subset of studies included in the ULR report, to support potential changes to the 2019 guideline. Materials/Methods: A systematic-review utilized research from the Oregon Health & Science University. Pacific Northwest EPC was used to update the 2019 AUA Guideline on rUTI in women with new evidence published through 2021. Results: Updates were made to reflect changes in literature since 2019. Updates include recent publications on antibiotic prophylaxis, non-antibiotic prophylaxis, and estrogen therapy. Conclusion: The presence of rUTI is crucial to the health of patients and its effects must be considered for the welfare of society. This document will undergo updating as the knowledge regarding current treatments and future treatment options continues to expand.

Automated summary

The purpose of this study is to update the 2019 guideline on recurrent uncomplicated urinary tract infections in women by the American Urological Association. The study utilized a systematic review and literature review to gather new evidence and make revisions to the guideline. The updates primarily focused on recent publications related to antibiotic prophylaxis, non-antibiotic prophylaxis, and estrogen therapy.